ARCH (Age-related changes in hematopoiesis) is a research project funded by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 813091.
ARCH aims to understand the causal relationship between the physiological changes in the hematopoietic system during lifespan and the occurrence of specific age-related hematological diseases, such as leukemias.
To this end ARCH brings together 15 research groups from 10 different countries and 5 Partner Organizations, including 2 European Consortia, represented through their italian nodes.
ARCH will form 15 highly qualified European experts in the field of Molecular Hematology needed to address the increasing medical and socio-economical burden inflicted by hematological diseases to the European population.
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]...
#ARCHprojectMSCA, #hematopoietic, #leukemias, #hematopoiesis, #StemCell, #Ageing
